THE TEXAS A&；M UNIVERSITY SYSTEM;ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
发明人:
Victor J. Hruby,Minying Cai,Caurnel Morgan
申请号：
US16876683
公开号：
US20200277331A1
申请日:
2020.05.18
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described herein. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (MC5R) peptide ligand according to the following:in a pharmaceutically acceptable carrier is administered to the subject. Xaa can be Cha or Pro. The MC5R peptide is a selective MC5R antagonist, and administration thereof to the subject can treat the depressive or anxiety disorder with clinical improvement observed in a relatively short time.
